Speaker: Margaret Carter, MD
After watching this activity, you should be able to:
- Utilize ultrasound to identify embryonic and fetal abnormalities associated with maternal diabetes;
- Understand the difference between abnormalities associated with maternal diabetes that develop during the embryonic period versus the fetal period; and
- Improve patient outcome by understanding the importance of optimizing glycemic control before and during pregnancy related to diabetic embryopathy and fetopathy.
For more information about this activity, please refer to this document: https://aium.s3.amazonaws.com/webinar/WebinarInfo/20MDEF.pdf